Eckert & Ziegler Future Growth
Future criteria checks 2/6
Eckert & Ziegler is forecast to grow earnings and revenue by 4.5% and 6.3% per annum respectively. EPS is expected to grow by 4.6% per annum. Return on equity is forecast to be 13% in 3 years.
Key information
4.6%
Earnings growth rate
4.6%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 6.0% |
| Future return on equity | 13.0% |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Eckert & Ziegler SE's (ETR:EUZ) Share Price Could Signal Some Risk
Aug 08
Does Eckert & Ziegler (ETR:EUZ) Have A Healthy Balance Sheet?
Jul 17Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All
Jun 20Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)
Jun 05Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?
May 13Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected
Apr 27Here's Why Eckert & Ziegler (ETR:EUZ) Can Manage Its Debt Responsibly
Apr 12Slowing Rates Of Return At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Leave Little Room For Excitement
Mar 06What Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) P/E Is Not Telling You
Jan 04Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has A Pretty Healthy Balance Sheet
Dec 20Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Hasn't Managed To Accelerate Its Returns
Nov 15What Is Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Share Price Doing?
Oct 01A Look At The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)
Aug 22These 4 Measures Indicate That Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Using Debt Reasonably Well
Jul 16Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Jun 22The Return Trends At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Look Promising
May 17Is Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ) Potentially Undervalued?
Mar 20Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns Have Hit A Wall
Jan 24We Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Can Stay On Top Of Its Debt
Oct 27Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Oct 05Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has Some Way To Go To Become A Multi-Bagger
Aug 21Is Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) A Risky Investment?
Jul 21Is There Now An Opportunity In Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Jun 13Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Will Pay A Larger Dividend Than Last Year At €0.50
May 13Returns At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Are On The Way Up
May 09Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50
Apr 24Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50
Mar 27Do Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Earnings Warrant Your Attention?
Mar 25When Should You Buy Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Feb 17Investors Will Want Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Growth In ROCE To Persist
Jan 31Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today
Dec 13Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns On Capital Are Heading Higher
Nov 01Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today
Sep 14Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Have The Makings Of A Multi-Bagger
Jul 29Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is An Interesting Stock
Jun 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 319 | 42 | 48 | 65 | 1 |
| 12/31/2025 | 293 | 36 | 17 | 54 | 1 |
| 12/31/2024 | 281 | 37 | 6 | 46 | 1 |
| 9/30/2024 | 278 | 38 | 32 | 53 | N/A |
| 6/30/2024 | 274 | 38 | 11 | 36 | N/A |
| 3/31/2024 | 256 | 34 | 11 | 38 | N/A |
| 12/31/2023 | 246 | 30 | 11 | 38 | N/A |
| 9/30/2023 | 240 | 31 | 17 | 43 | N/A |
| 6/30/2023 | 233 | 29 | 21 | 44 | N/A |
| 3/31/2023 | 230 | 30 | 10 | 35 | N/A |
| 12/31/2022 | 222 | 31 | 7 | 34 | N/A |
| 9/30/2022 | 215 | 27 | -9 | 29 | N/A |
| 6/30/2022 | 198 | 27 | -8 | 32 | N/A |
| 3/31/2022 | 186 | 27 | 5 | 39 | N/A |
| 12/31/2021 | 180 | 35 | 5 | 34 | N/A |
| 9/30/2021 | 180 | 33 | 26 | 38 | N/A |
| 6/30/2021 | 182 | 31 | 35 | 41 | N/A |
| 3/31/2021 | 176 | 30 | 22 | 28 | N/A |
| 12/31/2020 | 176 | 21 | 28 | 35 | N/A |
| 9/30/2020 | 172 | 21 | 21 | 28 | N/A |
| 6/30/2020 | 173 | 22 | 19 | 26 | N/A |
| 3/31/2020 | 179 | 21 | 30 | 37 | N/A |
| 12/31/2019 | 178 | 22 | 33 | 40 | N/A |
| 9/30/2019 | 178 | 22 | 30 | 37 | N/A |
| 6/30/2019 | 177 | 21 | 24 | 31 | N/A |
| 3/31/2019 | 177 | 20 | 22 | 28 | N/A |
| 12/31/2018 | 169 | 16 | 15 | 21 | N/A |
| 9/30/2018 | 162 | 16 | 15 | 20 | N/A |
| 6/30/2018 | 155 | 14 | N/A | 21 | N/A |
| 3/31/2018 | 142 | 11 | N/A | 23 | N/A |
| 12/31/2017 | 139 | 12 | N/A | 27 | N/A |
| 9/30/2017 | 131 | 11 | N/A | 31 | N/A |
| 6/30/2017 | 124 | 11 | N/A | 30 | N/A |
| 3/31/2017 | 117 | 11 | N/A | 24 | N/A |
| 12/31/2016 | 120 | 10 | N/A | 20 | N/A |
| 9/30/2016 | 127 | 9 | N/A | 14 | N/A |
| 6/30/2016 | 132 | 9 | N/A | 13 | N/A |
| 3/31/2016 | 142 | 11 | N/A | 16 | N/A |
| 12/31/2015 | 140 | 12 | N/A | 16 | N/A |
| 9/30/2015 | 137 | 11 | N/A | 17 | N/A |
| 6/30/2015 | 134 | 12 | N/A | 14 | N/A |
| 3/31/2015 | 130 | 8 | N/A | 13 | N/A |
| 12/31/2014 | 127 | 7 | N/A | 11 | N/A |
| 9/30/2014 | 124 | 8 | N/A | 13 | N/A |
| 6/30/2014 | 124 | 8 | N/A | 14 | N/A |
| 3/31/2014 | 121 | 9 | N/A | 15 | N/A |
| 12/31/2013 | 117 | 9 | N/A | 15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EUZ's forecast earnings growth (4.5% per year) is above the savings rate (1%).
Earnings vs Market: EUZ's earnings (4.5% per year) are forecast to grow slower than the German market (20.8% per year).
High Growth Earnings: EUZ's earnings are forecast to grow, but not significantly.
Revenue vs Market: EUZ's revenue (6.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: EUZ's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EUZ's Return on Equity is forecast to be low in 3 years time (13%).